$0.640800
0.046.37%
Last update: 12:41 PM
15 minutes delayed
BriaCell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BriaCell Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-06-14 | $0.11 | $-0.55 | 120.0 % |
Dec 2023 | 2024-03-18 | $-0.71 | $-0.20 | -255.0 % |
Mar 2023 | 2023-06-14 | $-0.32 | $-0.47 | 31.9 % |
Dec 2022 | 2023-03-16 | $-0.77 | $-0.37 | -108.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
BriaCell Therapeutics (BCTX) is scheduled to report earnings on December 12, 2024. The last reported earnings were for reported on June 14, 2024 for Q3.
The Actual EPS was $0.11, which beat the estimate of $-0.55.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.